Manawatu Standard

Local $1m trials for fast mastitis test

- Paul Mitchell paul.mitchell@stuff.co.nz

A Palmerston North agritech firm is pouring nearly $1 million of funding into commercial trials for a cheaper, faster farm-side test to help fight the common cattle infection mastitis.

Mastitis costs the dairy industry about $300m a year, but technology developed by Koru Diagnostic­s could soon be available to remove some of the guesswork with initial diagnosis.

Koru chief executive Rhys Mckinlay said the company recently secured more than $900,000 to develop its new mastitis test commercial­ly.

The test is expected to give farmers quicker, more accurate informatio­n to decide on treatment options for infected cattle.

‘‘Historical­ly, these are decisions the farmer or their vet would usually need to make on a best-guess basis.’’

Guessing wrong significan­tly increased treatment costs, and could permanentl­y hurt the infected cows, resulting in reduced milk production and lower fertility, he said.

Mckinlay said commercial­scale trials of the new test were under way, and the company expected to launch the product next year.

Koru’s test could detect specific mastitis bacteria in 10 minutes, a day faster than the next fastest test, and three to five days faster than traditiona­l methods, he said.

It could also help the dairy industry’s efforts to cut back on unnecessar­y use of antibiotic­s, to which infection strains can develop resistance.

Dairynz senior scientist Jane Lacy-hulbert said there were several tests heading to market that would enable farmers to use antibiotic­s more responsibl­y.

She said correctly identifyin­g the right strain of bacteria early was key to reducing the risk of it developing resistance.

‘‘Historical­ly, these are decisions the farmer or their vet would usually need to make on a bestguess basis.’’

 ??  ?? Koru Diagnostic­s boss Rhys Mckinlay is confident of the company’s future after receiving nearly $1 million in funding for trials of a test for mastitis.
Koru Diagnostic­s boss Rhys Mckinlay is confident of the company’s future after receiving nearly $1 million in funding for trials of a test for mastitis.
 ??  ??

Newspapers in English

Newspapers from New Zealand